Cancer Gene Therapy - Issue - nature.com science feeds Cancer Gene Therapy is the essential gene therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene therapy for cancer. http://www.nature.com/cgt/current_issue/ Nature Publishing Group en Copyright © Nature Publishing Group Cancer Gene Therapy 0929-1903 Copyright © Nature Publishing Group permissions@nature.com Cancer Gene Therapy http://www.nature.com/aj/images/logos_b_o_w/cgt.gif http://www.nature.com/cgt/ Dynamics of multiple myeloma tumor therapy with a recombinant measles virus http://feeds.nature.com/~r/cgt/rss/current/~3/CV4x2o8bFCs/cgt.2009.40 Dynamics of multiple myeloma tumor therapy with a recombinant measles virus

Cancer Gene Therapy 16, 873 (December 2009). doi:10.1038/cgt.2009.40

Authors: D Dingli, C Offord, R Myers, K-W Peng, T W Carr, K Josic, S J Russell & Z Bajzer

]]> Dynamics of multiple myeloma tumor therapy with a recombinant measles virus D Dingli C Offord R Myers K-W Peng T W Carr K Josic S J Russell Z Bajzer doi:10.1038/cgt.2009.40 Cancer Gene Therapy 16, 873 (December 2009) 2009-11-12 Cancer Gene Therapy June 5, 2009 10.1038/cgt.2009.40 http://dx.doi.org/10.1038/cgt.2009.40 16 12 873 882 http://dx.doi.org/10.1038/cgt.2009.40 Conditional interleukin-12 gene therapy promotes safe and effective antitumor immunity http://feeds.nature.com/~r/cgt/rss/current/~3/Rk53XXRDxxc/cgt.2009.33 Conditional interleukin-12 gene therapy promotes safe and effective antitumor immunity

Cancer Gene Therapy 16, 883 (December 2009). doi:10.1038/cgt.2009.33

Authors: H Komita, X Zhao, A K Katakam, P Kumar, M Kawabe, H Okada, J M Braughler & W J Storkus

]]> Conditional interleukin-12 gene therapy promotes safe and effective antitumor immunity H Komita X Zhao A K Katakam P Kumar M Kawabe H Okada J M Braughler W J Storkus doi:10.1038/cgt.2009.33 Cancer Gene Therapy 16, 883 (December 2009) 2009-11-12 Cancer Gene Therapy May 15, 2009 10.1038/cgt.2009.33 http://dx.doi.org/10.1038/cgt.2009.33 16 12 883 891 http://dx.doi.org/10.1038/cgt.2009.33 WT1 gene silencing by aerosol delivery of PEI–RNAi complexes inhibits B16-F10 lung metastases growth http://feeds.nature.com/~r/cgt/rss/current/~3/AkeW886u-ko/cgt.2009.35 WT1 gene silencing by aerosol delivery of PEI–RNAi complexes inhibits B16-F10 lung metastases growth

Cancer Gene Therapy 16, 892 (December 2009). doi:10.1038/cgt.2009.35

Authors: D E Zamora-Avila, P Zapata-Benavides, M A Franco-Molina, S Saavedra-Alonso, L M Trejo-Avila, D Reséndez-Pérez, J L Méndez-Vázquez, J Isaias-Badillo & C Rodríguez-Padilla

]]> WT1 gene silencing by aerosol delivery of PEI–RNAi complexes inhibits B16-F10 lung metastases growth D E Zamora-Avila P Zapata-Benavides M A Franco-Molina S Saavedra-Alonso L M Trejo-Avila D Reséndez-Pérez J L Méndez-Vázquez J Isaias-Badillo C Rodríguez-Padilla doi:10.1038/cgt.2009.35 Cancer Gene Therapy 16, 892 (December 2009) 2009-11-12 Cancer Gene Therapy May 22, 2009 10.1038/cgt.2009.35 http://dx.doi.org/10.1038/cgt.2009.35 16 12 892 899 http://dx.doi.org/10.1038/cgt.2009.35 Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy http://feeds.nature.com/~r/cgt/rss/current/~3/_5KFcwZK_A4/cgt.2009.39 Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy

Cancer Gene Therapy 16, 900 (December 2009). doi:10.1038/cgt.2009.39

Authors: D Boczkowski, J Lee, S Pruitt & S Nair

]]> Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy D Boczkowski J Lee S Pruitt S Nair doi:10.1038/cgt.2009.39 Cancer Gene Therapy 16, 900 (December 2009) 2009-11-12 Cancer Gene Therapy June 5, 2009 10.1038/cgt.2009.39 http://dx.doi.org/10.1038/cgt.2009.39 16 12 900 911 http://dx.doi.org/10.1038/cgt.2009.39 New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster http://feeds.nature.com/~r/cgt/rss/current/~3/RcWrv-OyoHI/cgt.2009.36 New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster

Cancer Gene Therapy 16, 912 (December 2009). doi:10.1038/cgt.2009.36

Authors: J F Spencer, J E Sagartz, W S M Wold & K Toth

]]> New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster J F Spencer J E Sagartz W S M Wold K Toth doi:10.1038/cgt.2009.36 Cancer Gene Therapy 16, 912 (December 2009) 2009-11-12 Cancer Gene Therapy May 29, 2009 10.1038/cgt.2009.36 http://dx.doi.org/10.1038/cgt.2009.36 16 12 912 922 http://dx.doi.org/10.1038/cgt.2009.36 Anticancer oncolytic activity of respiratory syncytial virus http://feeds.nature.com/~r/cgt/rss/current/~3/K6TefJw8GLg/cgt.2009.34 Anticancer oncolytic activity of respiratory syncytial virus

Cancer Gene Therapy 16, 923 (December 2009). doi:10.1038/cgt.2009.34

Authors: I Echchgadda, S Kota, I DeLa Cruz, A Sabbah, T Chang, R Harnack, V Mgbemena, B Chatterjee & S Bose

]]> Anticancer oncolytic activity of respiratory syncytial virus I Echchgadda S Kota I DeLa Cruz A Sabbah T Chang R Harnack V Mgbemena B Chatterjee S Bose doi:10.1038/cgt.2009.34 Cancer Gene Therapy 16, 923 (December 2009) 2009-11-12 Cancer Gene Therapy May 15, 2009 10.1038/cgt.2009.34 http://dx.doi.org/10.1038/cgt.2009.34 16 12 923 935 http://dx.doi.org/10.1038/cgt.2009.34 Anticancer oncolytic activity of respiratory syncytial virus http://feeds.nature.com/~r/cgt/rss/current/~3/w3hzkucKUbE/cgt.2009.42 Anticancer oncolytic activity of respiratory syncytial virus

Cancer Gene Therapy 16, 936 (December 2009). doi:10.1038/cgt.2009.42

Authors: I Echchgadda, S Kota, I DeLa Cruz, A Sabbah, T Chang, R Harnack, V Mgbemena, B Chatterjee & S Bose

]]> Anticancer oncolytic activity of respiratory syncytial virus I Echchgadda S Kota I DeLa Cruz A Sabbah T Chang R Harnack V Mgbemena B Chatterjee S Bose doi:10.1038/cgt.2009.42 Cancer Gene Therapy 16, 936 (December 2009) 2009-11-12 Cancer Gene Therapy 10.1038/cgt.2009.42 http://dx.doi.org/10.1038/cgt.2009.42 16 12 936 936 http://dx.doi.org/10.1038/cgt.2009.42